Taiyen Biotech Co Ltd (1737) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Taiyen Biotech Co Ltd (1737) has a cash flow conversion efficiency ratio of 0.025x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$173.44 Million ≈ $5.46 Million USD) by net assets (NT$6.91 Billion ≈ $217.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Taiyen Biotech Co Ltd to measure how many days the company can operate on defensive assets alone.
Taiyen Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Taiyen Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Taiyen Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Taiyen Biotech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DAE-IL Corporation
KO:092200
|
0.052x |
|
Eurocash S.A.
WAR:EUR
|
-0.653x |
|
Bursa Cimento Fabrikasi AS
IS:BUCIM
|
0.017x |
|
Liberty Latin America Ltd
NASDAQ:LILA
|
0.041x |
|
Citizens Community Bancorp Inc
NASDAQ:CZWI
|
0.021x |
|
KOSKISEN OYJ EO 1
F:EZ8
|
0.040x |
|
Terra Metals Ltd
AU:TM1
|
-0.001x |
|
A Paradise Acquisition Corp.
NASDAQ:APAD
|
0.000x |
Annual Cash Flow Conversion Efficiency for Taiyen Biotech Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Taiyen Biotech Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see 1737 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$6.81 Billion ≈ $214.67 Million |
NT$473.77 Million ≈ $14.93 Million |
0.070x | -29.77% |
| 2024-12-31 | NT$6.67 Billion ≈ $210.07 Million |
NT$660.12 Million ≈ $20.80 Million |
0.099x | +42.64% |
| 2023-12-31 | NT$6.55 Billion ≈ $206.32 Million |
NT$454.54 Million ≈ $14.32 Million |
0.069x | -20.37% |
| 2022-12-31 | NT$6.66 Billion ≈ $209.89 Million |
NT$580.69 Million ≈ $18.29 Million |
0.087x | -5.39% |
| 2021-12-31 | NT$6.51 Billion ≈ $205.21 Million |
NT$600.08 Million ≈ $18.91 Million |
0.092x | +72.78% |
| 2020-12-31 | NT$6.36 Billion ≈ $200.51 Million |
NT$339.36 Million ≈ $10.69 Million |
0.053x | -0.82% |
| 2019-12-31 | NT$6.15 Billion ≈ $193.85 Million |
NT$330.81 Million ≈ $10.42 Million |
0.054x | -26.43% |
| 2018-12-31 | NT$6.16 Billion ≈ $193.93 Million |
NT$449.83 Million ≈ $14.17 Million |
0.073x | -27.65% |
| 2017-12-31 | NT$6.02 Billion ≈ $189.62 Million |
NT$607.87 Million ≈ $19.15 Million |
0.101x | +6.43% |
| 2016-12-31 | NT$5.99 Billion ≈ $188.60 Million |
NT$568.06 Million ≈ $17.90 Million |
0.095x | +44.86% |
| 2015-12-31 | NT$5.86 Billion ≈ $184.65 Million |
NT$383.93 Million ≈ $12.10 Million |
0.066x | +2.83% |
| 2014-12-31 | NT$5.82 Billion ≈ $183.52 Million |
NT$371.06 Million ≈ $11.69 Million |
0.064x | +79.77% |
| 2013-12-31 | NT$5.73 Billion ≈ $180.67 Million |
NT$203.21 Million ≈ $6.40 Million |
0.035x | +49.72% |
| 2012-12-31 | NT$6.53 Billion ≈ $205.60 Million |
NT$154.46 Million ≈ $4.87 Million |
0.024x | -36.43% |
| 2011-12-31 | NT$6.61 Billion ≈ $208.23 Million |
NT$246.09 Million ≈ $7.75 Million |
0.037x | -18.56% |
| 2010-12-31 | NT$6.58 Billion ≈ $207.34 Million |
NT$300.89 Million ≈ $9.48 Million |
0.046x | -16.13% |
| 2009-12-31 | NT$6.57 Billion ≈ $206.92 Million |
NT$358.02 Million ≈ $11.28 Million |
0.055x | -16.99% |
| 2008-12-31 | NT$6.36 Billion ≈ $200.31 Million |
NT$417.51 Million ≈ $13.15 Million |
0.066x | +35.05% |
| 2007-12-31 | NT$6.63 Billion ≈ $208.94 Million |
NT$322.49 Million ≈ $10.16 Million |
0.049x | -26.86% |
| 2006-12-31 | NT$6.96 Billion ≈ $219.34 Million |
NT$462.88 Million ≈ $14.58 Million |
0.066x | -20.34% |
| 2005-12-31 | NT$6.90 Billion ≈ $217.39 Million |
NT$575.91 Million ≈ $18.14 Million |
0.083x | -76.90% |
| 2004-12-31 | NT$7.85 Billion ≈ $247.21 Million |
NT$2.84 Billion ≈ $89.32 Million |
0.361x | -22.55% |
| 2003-12-31 | NT$7.33 Billion ≈ $230.91 Million |
NT$3.42 Billion ≈ $107.73 Million |
0.467x | -- |
About Taiyen Biotech Co Ltd
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers beauty and skincare, and cleaning products; salt products; and leisure and pet foods, as well as health supplement. The company was founded in 1952 and is based in Tainan City, Taiwan.